Peroperative Fluid Management in Major Gynecological Cancer Surgeries
The Effect of Peroperative Fluid Management Strategy on Postoperative Renal Functions in Major Gyneco-oncological Surgeries
1 other identifier
interventional
180
1 country
1
Brief Summary
The aim of this study is to evaluate the effect of perioperative fluid management on postoperative kidney damage in gynecological cancer surgeries. The main question\[s\] it aims to answer are: Does fluid management applied with different hemodynamic monitoring methods affect the risk of postoperative AKI? In our clinic, three different fluid management strategies are applied depending on the anesthetist experience. Acute kidney injury will be evaluated according to the postoperative AKIN classification of conventional fluid therapy and targeted fluid therapy with noninvasive or minimally invasive monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 17, 2023
CompletedFirst Posted
Study publicly available on registry
October 26, 2023
CompletedNovember 27, 2023
November 1, 2023
7 months
October 17, 2023
November 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of acute kidney injury
Our primary aim was to evaluate the postoperative day(POD1 ) creatinine values(mg/dl)
Change from preoperative to postoperative day 1(POD1)creatinine values(mg/dl)
Secondary Outcomes (1)
Peroperative fluid amounts
during the operation period
Other Outcomes (2)
The intensive care unit admission
posoperatively up to 1 months
Length of stay
postoperative 30 days
Study Arms (3)
Conventional fluid therapy
EXPERIMENTALPatients who received conventional fluid therapy
Non invaziv goal directed therapy
EXPERIMENTALPatients who received non invaziv goal directed therapy
Minimal invaziv goal directed therapy
EXPERIMENTALPatients who received minimal invaziv goal directed therapy
Interventions
postoperative 24 hours
Eligibility Criteria
You may qualify if:
- \>18 years
- ASA II-III
- Those with normal renal function
You may not qualify if:
- Patients in renal insufficiency
- Patients with perioperative renal, ureter \& bladder invasion
- Patients in whom perioperative urine monitoring cannot be performed
- Patients undergoing HIPEC
- Patients with missing data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Başakşehir Çam and Sakura City Hospital
Istanbul, Basaksehir, 3268, Turkey (Türkiye)
Related Publications (5)
Yildiz GO, Hergunsel GO, Sertcakacilar G, Akyol D, Karakas S, Cukurova Z. Perioperative goal-directed fluid management using noninvasive hemodynamic monitoring in gynecologic oncology. Braz J Anesthesiol. 2022 May-Jun;72(3):322-330. doi: 10.1016/j.bjane.2021.12.012. Epub 2022 Feb 1.
PMID: 35121063RESULTYu J, Che L, Zhu A, Xu L, Huang Y. Goal-Directed Intraoperative Fluid Therapy Benefits Patients Undergoing Major Gynecologic Oncology Surgery: A Controlled Before-and-After Study. Front Oncol. 2022 Apr 6;12:833273. doi: 10.3389/fonc.2022.833273. eCollection 2022.
PMID: 35463383RESULTRusso A, Aceto P, Grieco DL, Anzellotti GM, Perilli V, Costantini B, Romano B, Scambia G, Sollazzi L, Antonelli M. Goal-directed hemodynamic management in patients undergoing primary debulking gynaecological surgery: A matched-controlled precision medicine study. Gynecol Oncol. 2018 Nov;151(2):299-305. doi: 10.1016/j.ygyno.2018.08.034. Epub 2018 Sep 7.
PMID: 30201234RESULTHasselgren E, Hertzberg D, Camderman T, Bjorne H, Salehi S. Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2021 May;161(2):402-407. doi: 10.1016/j.ygyno.2021.02.034. Epub 2021 Mar 12.
PMID: 33715894RESULTMcKenny M, Conroy P, Wong A, Farren M, Gleeson N, Walsh C, O'Malley C, Dowd N. A randomised prospective trial of intra-operative oesophageal Doppler-guided fluid administration in major gynaecological surgery. Anaesthesia. 2013 Dec;68(12):1224-31. doi: 10.1111/anae.12355. Epub 2013 Sep 30.
PMID: 24116747RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Duygu Akyol
Başakşehir Çam & Sakura City Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 17, 2023
First Posted
October 26, 2023
Study Start
January 1, 2023
Primary Completion
August 1, 2023
Study Completion
September 1, 2023
Last Updated
November 27, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share